ClinicalTrials.gov
ClinicalTrials.gov Menu

Incidence and Prevalence of Juvenile Dermatomyositis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03432455
Recruitment Status : Recruiting
First Posted : February 14, 2018
Last Update Posted : February 14, 2018
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Brief Summary:
This is a descriptive, retrospective, multi-center, cross-sectional and observational epidemiological study of incidence and prevalence of juvenile dermatomyositis in Alsace from 2000 to 2015. Alsace is a French region with a low migratory flow

Condition or disease
Juvenile Dermatomyositis

Study Type : Observational
Estimated Enrollment : 22 participants
Observational Model: Cohort
Time Perspective: Other
Official Title: Incidence and Prevalence of Juvenile Dermatomyositis in Alsace Between 2000 to 2015
Actual Study Start Date : February 7, 2018
Estimated Primary Completion Date : January 2019
Estimated Study Completion Date : January 2019





Primary Outcome Measures :
  1. Identify incident and prevalent cases of juvenile dermatomyositis according to Bohan and Peter's criteria at january 1st, 2016 via capture/recapture strategy [ Time Frame: The period from from January 1st, 2000 to December 31st, 2015 will be examined ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 16 Years   (Child)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Patient who have a dermatomyositis according to the diagnostic criteria of Bohan and Peter of 1975
Criteria

Inclusion Criteria:

  • Age under 16 years
  • Have a dermatomyositis according to the diagnostic criteria of Bohan and Peter of 1975

Exclusion Criteria:

  • Refusal to participate in the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03432455


Contacts
Contact: Dan LIPSKER, MD, PhD 33.3.88.11.61.79 dan.lipsker@chru-strasbourg.fr
Contact: Céline RAMSTEIN, MD 33.3.88.11.61.79 celine.ramstein@chru-strasbourg.fr

Locations
France
Service de Dermatologie Recruiting
Strasbourg, France, 67091
Contact: Dan LIPSKER, MD, PhD    33.3.88.11.61.79    dan.lipsker@chru-strasbourg.fr   
Contact: Céline Ramstein, MD    33.3.88.11.61.79    celine.ramstein@chru-strasbourg.fr   
Principal Investigator: Dan LIPSKER, MD, PhD         
Sub-Investigator: Céline Ramstein, MD         
Sponsors and Collaborators
University Hospital, Strasbourg, France

Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT03432455     History of Changes
Other Study ID Numbers: 6784
First Posted: February 14, 2018    Key Record Dates
Last Update Posted: February 14, 2018
Last Verified: February 2018

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University Hospital, Strasbourg, France:
Incidence
prevalence
epidemiology
juvenile dermatomyositis
inflammatory myopathy

Additional relevant MeSH terms:
Dermatomyositis
Polymyositis
Myositis
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases
Connective Tissue Diseases
Skin Diseases